Menu
No results found.
Weekly Share Price & Valuation Overview
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
- ROE ≥15% reflects strong returns on shareholder equity.
- Revenue growth ≥10% indicates solid top-line momentum.
- Quick ratio <0.8 — tight near-term liquidity without inventory.
- Market Cap Total equity value of the company (share price × shares outstanding).
- USD 275.33B
- Enterprise Value Operating value: market cap + total debt − cash.
- USD 332.57B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- USD 422.82B
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- USD 461.84
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 23.10
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 2.91%
- Shares Outstanding
- 905.67M
- Float Shares
- 897.83M
- Implied Shares Outstanding
- 911.26M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
4.61%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
5.04%
- ROA Return on assets: net income ÷ total assets.
-
6.46%
- ROE Excellent Return on equity: net income ÷ shareholder equity.
-
21.65%
- Revenue Growth Strong Year-over-year revenue growth.
-
12.90%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-17.60%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-19.20%
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.77
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.76
- Total Cash Cash and equivalents.
- USD 32.02B
- Total Debt Short + long-term interest-bearing debt.
- USD 79.19B
- Net Debt Total debt − cash (negative = net cash).
- USD 47.17B
- EBITDA & EBITDA margin suppressed (implausible vs revenue or not meaningful for financials).
- Gross Profit hidden for financial institutions (often redundant with revenue).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.